Viena Karanko

2.3k total citations · 1 hit paper
12 papers, 1.8k citations indexed

About

Viena Karanko is a scholar working on Epidemiology, Microbiology and Health. According to data from OpenAlex, Viena Karanko has authored 12 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Microbiology and 3 papers in Health. Recurrent topics in Viena Karanko's work include Bacterial Infections and Vaccines (9 papers), Pneumonia and Respiratory Infections (8 papers) and Influenza Virus Research Studies (5 papers). Viena Karanko is often cited by papers focused on Bacterial Infections and Vaccines (9 papers), Pneumonia and Respiratory Infections (8 papers) and Influenza Virus Research Studies (5 papers). Viena Karanko collaborates with scholars based in Finland and United States. Viena Karanko's co-authors include Heikki Peltola, Helena Käyhty, P. H. Makela, P. Helena Mäkelä, Martti Virtanen, Seppo Sarna, Kari Cantell, Olli P. Heinonen, Martti Valle and Mikko Paunio and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PEDIATRICS.

In The Last Decade

Viena Karanko

12 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b

1983 461 citations Heikki Peltola, Viena Karanko et al. The Journal of Infectious Diseases profile →

Peers

Viena Karanko

EPIDE

MICRO

HEALT

IMMUN

RNMI

Adamadia Deforest United States

Hanne Nøkleby Norway

Kathryn M. Edwards United States

Paul Balmer United Kingdom

Paola Mastrantonio Italy

Joel S. Samuelson United States

A. A. McLean United States

L. Pais United States

Lorry G. Rubin United States

Luc Hessel France

Adamadia Deforest United States

Viena Karanko

967 ×0.7

EPIDE

775 ×0.7

MICRO

194 ×0.7

HEALT

147 ×0.6

IMMUN

56 ×0.3

RNMI

Citations per year, relative to Viena Karanko Viena Karanko (= 1×) peers Adamadia Deforest

Countries citing papers authored by Viena Karanko

Since Specialization

Citations

This map shows the geographic impact of Viena Karanko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viena Karanko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viena Karanko more than expected).

Fields of papers citing papers by Viena Karanko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viena Karanko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viena Karanko. The network helps show where Viena Karanko may publish in the future.

Co-authorship network of co-authors of Viena Karanko

This figure shows the co-authorship network connecting the top 25 collaborators of Viena Karanko. A scholar is included among the top collaborators of Viena Karanko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viena Karanko. Viena Karanko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Peltola, Heikki, Olli P. Heinonen, Martti Valle, et al.. (1994). The Elimination of Indigenous Measles, Mumps, and Rubella from Finland by a 12-Year, Two-Dose Vaccination Program. New England Journal of Medicine. 331(21). 1397–1402. 233 indexed citations

Paunio, Mikko, Martti Virtanen, Heikki Peltola, et al.. (1991). Increase of Vaccination Coverage by Mass Media and Individual Approach: Intensified Measles, Mumps, and Rubella Prevention Program in Finland. American Journal of Epidemiology. 133(11). 1152–1160. 53 indexed citations

Käyhty, Helena, Heikki Peltola, Juhani Eskola, et al.. (1989). Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age.. PubMed. 84(6). 995–9. 22 indexed citations

Eskola, Juhani, Heikki Peltola, Aino K. Takala, et al.. (1987). Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in Infancy. New England Journal of Medicine. 317(12). 717–722. 208 indexed citations

Peltola, Heikki, Tapio Kurki, Martti Virtanen, et al.. (1986). RAPID EFFECT ON ENDEMIC MEASLES, MUMPS, AND RUBELLA OF NATIONWIDE VACCINATION PROGRAMME IN FINLAND. The Lancet. 327(8473). 137–139. 70 indexed citations

Eskola, Juhani, Heikki Peltola, P. Helena Mäkelä, et al.. (1985). ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE. The Lancet. 325(8439). 1184–1186. 88 indexed citations

Peltola, Heikki, Assad Safary, Helena Käyhty, Viena Karanko, & Francis André. (1985). Evaluation of Two Tetravalent (ACYW135) Meningococcal Vaccines in Infants and Small Children: A Clinical Study Comparing Immunogenicity of O-Acetyl-Negative and O-Acetyl-Positive Group C Polysaccharides. PEDIATRICS. 76(1). 91–96. 56 indexed citations

Käyhty, Helena, Viena Karanko, Heikki Peltola, & P. Helena Mäkelä. (1984). Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.. PubMed. 74(5). 857–65. 134 indexed citations

Käyhty, Helena, Viena Karanko, Heikki Peltola, & P. Helena Mäkelä. (1984). Serum Antibodies After Vaccination with Haemophilus influenzae Type b Capsular Polysaccharide and Responses to Reimmunization: No Evidence of Immunologic Tolerance or Memory. PEDIATRICS. 74(5). 857–865. 105 indexed citations

10.

Peltola, Heikki, et al.. (1983). The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b. The Journal of Infectious Diseases. 147(6). 1100–1100. 461 indexed citations breakdown →

11.

Käyhty, Helena, Viena Karanko, Heikki Peltola, Seppo Sarna, & P. Helena Mäkelä. (1980). Serum Antibodies to Capsular Polysaccharide Vaccine of Group A Neisseria meningitidis Followed for Three Years in Infants and Children. The Journal of Infectious Diseases. 142(6). 861–868. 84 indexed citations

12.

Peltola, Heikki, P. Helena Mäkelä, Helena Käyhty, et al.. (1977). Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age. New England Journal of Medicine. 297(13). 686–691. 273 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact